Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;13(4):237-41.

Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients

A Sioulis  1 , P Malindretos, A Makedou, P Makris, D Grekas
Affiliations

Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients

A Sioulis et al. Hippokratia. 2009 Oct.

Abstract

Background and aim: The aim of our study was to assess the coagulation factors as endothelial dysfunction markers and prospectively their association with thrombotic episodes in chronic hemodialysis patients.

Patients and methods: Fifty-four randomly selected patients on chronic hemodialysis (HD), 34 men and 20 women were included in this study. Their mean age was 56 years and the mean hemodialysis duration was 53.0861.92 months. The variations of tissue factor pathway inhibitor (TFPI), thrombomodulin (TM) and von Willebrand factor (vWF) were studied. The above-mentioned parameters were measured before and after HD session. Low molecular weight heparin (tinzaparin) was administered to all patients during hemodialysis. The results were compared with those obtained from 20 healthy volunteer-controls, age and sex matched. After the initial assessment, all patients were followed for a period of 15 months.

Results: Two patients experienced one hemorrhagic event each, regarding the upper and/or the lower gastrointestinal tract. Twenty patients showed at least one thrombotic episode. Eleven patients presented fistula thrombosis, four angina pectoris incidents and five thrombosis of the lower limbs. The rest of the patients did not experience any clinical symptomatology that could be attributed to coagulation disorders. Parameter differences between patients and controls were statistically significant (p<0.005 for TFPI and p<0.001 for TM and vWF) and were improved after hemodialysis session. The age and the elevated levels of the vWF were found to be significantly different (p<0.03 and p<0.02 respectively) between the groups of patients who experienced or not thrombotic episodes.

Conclusions: Coagulation factors TFPI, TM, and vWF are increased in hemodialysis patients and the clinical disorders are mainly thrombotic episodes. The age of patients and the elevated levels of vWF are associated with the thrombotic incidents. Hemodialysis contributes in the improvement of these coagulation factors, which could be considered as biological risk markers of endothelial dysfunction in chronic HD patients.

Keywords: coagulation factors; endothelial dysfunction; hemodialysis; thrombotic episodes.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Histogram showing the levels vWF, TM and TFPI before and after HD in comparison to control group
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Εditorial. Controlling the epidemic of cardiovascular renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis. 1998;32:853–906. - PubMed
    1. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stoke Incidence Collaboration. Stroke. 1997;28:491–499. - PubMed
    1. DiMinno G, Martinez J, McKean ML, DeLaRosa J, Burke JF, Murphy S. Platelet dysfunction in uremia: Multifaceted defect partially corrected by dialysis. Am J Med. 1985;79:552–559. - PubMed
    1. Gordge MP, Neild GH. Platelet function in uremia. Platelets. 1991;2:115–123. - PubMed
    1. Rabiner SF. Uremic bleeding. In: Spaet TH, editor. Progress in Hemostasis and Thrombosis. New York: Grune & Stratton; 1972. pp. 233–250. - PubMed

LinkOut - more resources